Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer

Cancer Biology and Therapy

Volumn 6, Issue 6, 2007, Pages 832-839

  Katoh, Masaru ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

FGF; Gastric cancer; Helicobacter pylori; Notch; Single nucleotide polymorphism; Stem cell biology; Systems medicine; WNT

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; JAGGED1; LIPOPOLYSACCHARIDE; MYC PROTEIN; NOTCH1 RECEPTOR; PROTEIN PATCHED 1; SECRETED FRIZZLED RELATED PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; WNT3 PROTEIN; WNT5A PROTEIN; BONE MORPHOGENETIC PROTEIN; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

CANCER PATIENT; CANCER STEM CELL; CLINICAL TRIAL; EPITHELIUM CELL; GENE MUTATION; GENETIC PREDISPOSITION; HEDGEHOG; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOCOMPETENT CELL; NUCLEOTIDE SEQUENCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; STOMACH EPITHELIUM; STOMACH PARIETAL CELL; STOMACH SECRETION; UPREGULATION; BIOLOGICAL MODEL; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MUTATION; SIGNAL TRANSDUCTION; STEM CELL; STOMACH TUMOR; VIROLOGY;

BONE MORPHOGENETIC PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GERM-LINE MUTATION; HEDGEHOG PROTEINS; HELICOBACTER INFECTIONS; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS; STOMACH NEOPLASMS; WNT PROTEINS;

EID: 42449146614     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.6.4196     Document Type: Review

References (84)

1. Pisani P, Bray F, Parkin DM. Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97:72-81.
2. Katoh M, Terada M. Oncogenes and tumor suppressor genes. In: Nishi M, ed. Gastric cancer. Tokyo: Splinger-Verlag, 1993:196-208.
3. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005; 11:466-72.
4. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64:31-49.
5. Katoh M, Katoh M. Evolutionary recombination hotspot around GSDML~GSDM locus is closely linked to oncogenomic recombination hotspot around PPP1R1B~ERBB2~GRB7 amplicon. Int J Oncol 2004; 24:757-63.
6. Katoh M, Katoh M. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene located on human chromosome 10q26. Int J Oncol 2003; 22:1155-9.
7. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-5.
8. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-31.
9. Peek Jr RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208:233-48.
10. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32:1473-7.
11. Katoh M. WNT and FGF gene clusters. Int J Oncol 2002; 21:1269-73.
12. Radtke F, Clevers H, Riccio O. From gut homoestasis to cancer. Curr Mol Med 2006; 6:275-89.
13. Katoh M, Katoh M. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis, and cancer. Int J Mol Med 2007; 19:273-8.
14. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999; 284:770-6.
15. Radtke F, Raj K. The role of Notch in tumorigenesis: Oncogene or tumor suppressor? Nat Rev Cancer 2003; 3:765-7.
16. Katoh M, Katoh M. Notch signaling in the gastrointestinal tract. Int J Oncol 2007; 30:247-51.
17. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16:139-49.
18. Katoh M, Katoh M. FGF signaling network in the gastrointestinal tract. Int J Oncol 2006; 29:163-8.
19. Katoh M, Katoh M. Crosstalk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biol Ther 2006; 5:1059-64.
20. Lum L, Beachy PA. The Hedgehog response network: Sensors, switches, and routers. Science 2004; 304:1755-9.
21. Katoh Y, Katoh M. Hedgehog signaling in gastric cancer. Cancer Biol Ther 2005; 4:1050-4.
22. Katoh Y, Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network. Int J Mol Med 2006; 18:1019-23.
23. Heldin CH, Miyazono K, ten Dijke P. TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390:465-71.
24. Massague J. TGFβ signal transduction. Annu Rev Biochem 1998; 67:753-91.
25. Katoh Y, Katoh M. Comparative integromics on BMP/GDF family. Int J Mol Med 2006; 17:951-5.
26. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16.
27. Katoh M, Katoh M. Bioinformatics for cancer management in the post-genome era. Technol Cancer Res Treat 2006; 5:169-76.
28. Katoh M. Paradignshift in gene-finding method: From bench-top approach to desk-top approach. Int J Mol Med 2002; 10:677-82.
29. Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear β-catenin-TCF complex. Cell 2002; 109:47-60.
30. Katoh M, Katoh M. Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico. Int J Mol Med 2003; 12:643-49.
31. Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT. PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 2001; 3:628-36.
32. Price MA. CKI, there's more than one: Casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev 2006; 20:399-410.
33. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998; 281:1509-12.
34. Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE. FGF20 and DKK1 are transcriptional target of β-catenin, and FGF20 is implicated in cancer and development. EMBO J 2005; 24:73-84.
35. Katoh M, Katoh M. Comparative genomics on FGF20 orthologs. Oncol Rep 2005; 14:287-90.
36. Katoh M, Katoh M. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 2006; 17:681-5.
37. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3β. J Biol Chem 2005; 280:1457-64.
38. Noubissi FK, Elcheva I, Bhatia N, Shakoori A, Ougolkov A, Liu J, Minamoto T, Ross J, Fuchs SY, Spiegelman VS. CRD-BP mediates stabilization of βTrCP1 and c-myc mRNA in response to β-catenin signalling. Nature 2006; 441:898-901.
39. Lu X, Borchers AG, Jolicoeur C, Rayburn H, Baker JC, Tessier-Lavigne M. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 2004; 430:93-8.
40. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol Rep 2005; 14:1583-8.
41. 2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase Iα signaling in human mammary epithelial cells. Mol Cell Biol 2006; 26:6024-36.
42. Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol 2001; 19:1003-7.
43. Saitoh T, Katoh M. Frequent up-regulation of WNT5A mRNA in primary gastric cancer. Int J Mol Med 2002; 9:515-9.
44. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Phys 2003; 194:237-55.
45. Katoh M, Katoh M. Identification and characterization of human HES2, HES3, and HES5 genes in silico. Int J Oncol 2004; 25:529-34.
46. Katoh M, Katoh M. Identification and characterization of human HESL, rat Hesl and rainbow trout hesl genes in silico. Int J Mol Med 2004; 14:747-51.
47. Sekine A, Akiyama Y, Yanagihara K, Yuasa Y. Hath1 up-regulates gastric mucin gene expression in gastric cells. Biochem Biophys Res Commun 2006; 344:1166-71.
48. Katoh M, Katoh M. Evolutionary conservation of CCND1-ORAOV1-FGF19- FGF4 locus from zebrafish to human. Int J Mol Med 2003; 12:45-50.
49. Nakazawa K, Yashiro M, Hirakawa K. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 2003; 63:8848-52.
50. Marigo V, Roberts DJ, Lee SM, Tsukurov O, Levi T, Gastier JM, Epstein DJ, Gilbert DJ, Copeland NG, Seidman CE, McMahon AP, Tabin C. Cloning, expression, and chromosomal location of SHH and IHH: Two human homologues of the Drosophila segment polarity gene hedgehog. Genomics 1995; 28:44-51.
51. Katoh Y, Katoh M. Identification and characterization of rat Desert hedgehog and Indian hedgehog genes in silico. Int J Oncol 2005; 26:545-9.
52. Katoh Y, Katoh M. Comparative genomics on Sonic hedgehog orthologs. Oncol Rep 2005; 14:1087-90.
53. Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E, Taipale J. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 2006; 124:47-59.
54. Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, Blaas L, Schmid C, Hauser-Kronberger C, Regl G, Philpott MP, Aberger F. Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 2006; 26:6283-99.
55. Katoh Y, Katoh M. WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 2006; 17:171-5.
56. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature 2003; 425:846-51.
57. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, Evers BM, Zhang H, Xie J. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 2005; 26:1698-705.
58. Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR. Hedgehog-interacting protein is highly expressed in endothelial cells, but down-regulated during angiogenesis and in several human tumors. BMC Cancer 2004; 4:43.
59. Katoh M, Katoh M. CER1 is a common target of WNT and NODAL signaling pathways in human embryonic stem cells. Int J Mol Med 2006; 17:795-9.
60. Katoh M, Katoh M. Identification and characterization of human CKTSF1B2 and CKTSF1B3 genes in silico. Oncol Rep 2004; 12:423-7.
61. Marques S, Borges AC, Silva AC, Freitas S, Cordenonsi M, Belo JA. The activity of the Nodal antagonist Cerl-2 in the mouse node is required for correct L/R body axis. Genes Dev 2004; 18:2342-7.
62. Katoh M, Terada M. Overexpression of bone morphogenetic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. Gastroenterol Jpn 1996; 31:137-9.
63. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 1999; 397:176-80.
64. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
65. Odenbreit S, Plus J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287:1497-500.
66. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5:1166-74.
67. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KEL, Lissowska J, Zatonski W, Schoenberg JB, Blot WJ, Mowat NAG, Fraumeni Jr JF, El-Omar EM. A functional polymorphism of Toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (in press).
68. Saitoh T, Kirikoshi H, Mine T, Katoh M. Proto-oncogene WNT10B is up-regulated by tumor necrosis factor a in human gastric cancer cell line MKN45. Int J Oncol 2001; 19:1187-92.
69. van den Brink GR, Hardwick JC, Tytgat GN, Brink MA, Ten Kate FJ, Van Deventer SJ, Peppelenbosch MP. Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology 2001; 121:317-28.
70. Bleuming SA, Kodach LL, Garcia Leon MJ, Richel DJ, Peppelenbosch MP, Reitsma PH, Hardwick JC, van den Brink GR. Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol 2006; 209:190-97.
71. Takeichi M. The cadherins: Cell-cell adhesion molecules controlling animal morphogenesis. Development 1988; 102:639-55.
72. Katoh M. Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 2005; 27:1677-83.
73. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392:402-5.
74. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni Jr JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
75. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro AC, Campos ML, Van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125:364-371.
76. Katoh M, Katoh M. Pharmacogenomics on gastric cancer. Cancer Biol Ther 2004; 3:566-7.
77. Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, Bruseo C, Wood AW, Shivdasani RA. Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex. Cancer Cell 2004; 5:91-102.
78. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discovery 2006; 5:997-1014.
79. Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Gonzales C, Dean RA, May PC. Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology 2006; 66:602-4.
80. Hyde LA, McHugh NA, Chen J, Zhang Q, Manfra D, Nomeir AA, Josien H, Bara T, Clader JW, Zhang L, Parker EM, Higgins GA. Studies to investigate the in-vivo therapeutic window of the γ-secretase inhibitor LY411575 in the CRND8 mouse. J Pharmacol Exp Ther 2006; 319:1133-43.
81. Ezzat S, Huang P, Dackiw A, Asa SL. Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. Clin Cancer Res 2005; 11:1336-41.
82. Sessa C, Vigano L, Grasselli G, Trigo J, Marimon I, Llado A, Locatelli A, Ielmini N, Marsoni S, Gianni L. Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing. Eur J Cancer 2006; 42:171-8.
83. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of Smoothened activity. Proc Natl Acad Sci USA 2002; 99:14071-6.
84. Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Wichterle H, Kon C, Gatchalian C, Porter JA, Rubin LL, Wang FY. Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 2003; 100:4616-21.